Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacity

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Giefing, Maciej ^a,f   Winoto Morbach, Supandi ^a   Sosna, Justyna ^a   Döring, Claudia ^b   Klapper, Wolfram ^c   Küppers, Ralf ^d   Böttcher, Sebastian ^e   Adam, Dieter ^a   Siebert, Reiner ^a   Schütze, Stefan ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c Department of Pathology   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f INSTITUTE OF HUMAN GENETICS   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL LINE, TUMOR; DNA COPY NUMBER VARIATIONS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MEMBRANE GLYCOPROTEINS; MICROARRAY ANALYSIS; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; REED-STERNBERG CELLS; SUPEROXIDES;

EID: 84893232606     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084928     Document Type: Article

References (42)

1. Richards S, Watanabe C, Santos L, Craxton A, Clark EA (2008) Regulation of B-cell entry into the cell cycle. Immunol Rev 224: 183-200. doi:10.1111/j.1600-065X.2008.00652.x. PubMed: 18759927.
2. Johnston RB Jr (2001) Clinical aspects of chronic granulomatous disease. Curr Opin Hematol 8: 17-22. doi:10.1097/00062752-200101000-00004. PubMed: 11138621.
3. Jurkowska M, Bernatowska E, Bal J (2004) Genetic and biochemical background of chronic granulomatous disease. Arch Immunol Ther Exp 52: 113-120. (Pubitemid 38685051)
4. Kobayashi S, Imajoh-Ohmi S, Nakamura M, Kanegasaki S (1990) Occurrence of cytochrome b558 in B-cell lineage of human lymphocytes. Blood 75: 458-461. PubMed: 2153037. (Pubitemid 20035278)
5. Kobayashi S, Imajoh-Ohmi S, Kuribayashi F, Nunoi H, Nakamura M et al. (1995) Characterization of the superoxide-generating system in human peripheral lymphocytes and lymphoid cell lines. J Biochem 117: 758-765. PubMed: 7592536.
6. Sumimoto H, Miyano K, Takeya R (2005) Molecular composition and regulation of the Nox family NAD(P)H oxidases. Biochem Biophys Res Commun 338: 677-686. doi:10.1016/j.bbrc.2005.08.210. PubMed: 16157295. (Pubitemid 41540615)
7. Owusu-Ansah E, Banerjee U (2009) Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation. Nature 461: 537-541. doi:10.1038/nature08313. PubMed: 19727075.
8. Crotzer VL, Matute JD, Arias AA, Zhao H, Quilliam LA et al. (2012) Cutting edge: NADPH oxidase modulates MHC class II antigen presentation by B-cells. J Immunol 189: 3800-3804. doi:10.4049/jimmunol.1103080. PubMed: 22984083.
9. Lan Q, Zheng T, Shen M, Zhang Y, Wang SS et al. (2007) Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma. Hum Genet 121: 161-168. doi:10.1007/s00439-006-0288-9. PubMed: 17149600. (Pubitemid 46404450)
10. Rossi D, Rasi S, Franceschetti S, Capello D, Castelli A et al. (2009) Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-celllymphoma treated with RCHOP21. Leukemia 23: 1118-1126. doi:10.1038/leu.2008.398. PubMed: 19448608.
11. Hoffmann M, Schirmer MA, Tzvetkov MV, Kreuz M, Ziepert M et al. (2010) German Study Group for High-Grade Non-Hodgkin Lymphoma. A functional polymorphism in the NAD(P)H oxidase subunit CYBA is related to gene expression, enzyme activity, and outcome in non-Hodgkin lymphoma. Cancer Res 70: 2328-2338. doi:10.1158/1538-7445.AM10-2328. PubMed: 20215507.
12. Giefing M, Arnemann J, Martin-Subero JI, Nieländer I, Bug S et al. (2008) Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines. Br J Haematol 142: 916-924. doi:10.1111/j.1365- 2141.2008.07262.x. PubMed: 18671701.
13. Küppers R, Klein U, Schwering I, Distler V, Bräuninger A et al. (2003) Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest 111: 529-537. doi:10.1172/JCI16624. PubMed: 12588891. (Pubitemid 36228010)
14. Brune V, Tiacci E, Pfeil I, Döring C, Eckerle S et al. (2008) Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med 205: 2251-2268. doi:10.1084/jem.20080809. PubMed: 18794340.
15. Horie R, Watanabe T, Morishita Y, Ito K, Ishida T et al. (2002) Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells. Oncogene 21: 2493-2503. doi:10.1038/sj.onc. 1205337. PubMed: 11971184. (Pubitemid 34438102)
16. Ammerpohl O, Haake A, Pellissery S, Giefing M, Richter J et al. (2012) Array-based DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B-cell specific genes. Leukemia 26: 185-188. doi:10.1038/leu.2011.194. PubMed: 21818115.
17. Chandel NS, Schumacker PT, Arch RH (2001) Reactive oxygen species are downstream products of TRAF-mediated signal transduction. J Biol Chem 276: 42728-42736. doi:10.1074/jbc.M103074200. PubMed: 11559697.
18. Yazdanpanah B, Wiegmann K, Tchikov V, Krut O, Pongratz C et al. (2009) Riboflavin kinase couples TNF receptor 1 to NADPH oxidase. Nature 460: 1159-1163. doi:10.1038/nature08206. PubMed: 19641494.
19. Miller FJ Jr, Chu X, Stanic B, Tian X, Sharma RV et al. (2010) A differential role for endocytosis in receptor-mediated activation of Nox1. Antioxid Redox Signal 12: 583-593. doi:10.1089/ars.2009.2857. PubMed: 19737091.
20. Li Q, Spencer NY, Oakley FD, Buettner GR, Engelhardt JF (2009) Endosomal Nox2 facilitates redox-dependent induction of NF-kappaB by TNF-alpha. Antioxid Redox Signal 11: 1249-1263. doi:10.1089/ars.2008.2407. PubMed: 19113817.
21. Li Q, Harraz MM, Zhou W, Zhang LN, Ding W et al. (2006) Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes. Mol Cell Biol 26: 140-154. doi:10.1128/MCB.26.1.140-154.2006. PubMed: 16354686.
22. Oakley FD, Abbott D, Li Q, Engelhardt JF (2009) Signaling components of redox active endosomes: the redoxosomes. Antioxid Redox Signal 11: 1313-1333. PubMed: 19072143.
23. Schumacher MA, Schmitz R, Brune V, Tiacci E, Döring C et al. (2010) Mutations in the genes coding for the NF-κB regulating factors κBaα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma. Haematologica 95: 153-157. doi:10.3324/haematol.2009.010157. PubMed: 19648161.
24. Fedyk ER, Phipps RP (1994) Reactive oxygen species and not lipoxygenase products are required for mouse B-lymphocyte activation and differentiation. Int J Immunopharmacol 16: 533-546. doi:10.1016/0192-0561(94)90105-8. PubMed: 7928003.
25. Ago T, Liu T, Zhai P, Chen W, Li H et al. (2008) A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell 133: 978-993. doi:10.1016/j.cell.2008.04.041. PubMed: 18555775. (Pubitemid 351787743)
26. Finkel T (2011) Signal transduction by reactive oxygen species. J Cell Biol 194: 7-15. doi:10.1083/jcb.201102095. PubMed: 21746850.
27. Ehlers A, Oker E, Bentink S, Lenze D, Stein H et al. (2008) Histone acetylation and DNA demethylation of B-cells result in a Hodgkin-like phenotype. Leukemia 22: 835-841. doi:10.1038/leu.2008.12. PubMed: 18256685. (Pubitemid 351552633)
28. Overbeck BM, Martin-Subero JI, Ammerpohl O, Klapper W, Siebert R et al. (2012) ETS1 encoding a transcription factor involved in B-cell differentiation is recurrently deleted and downregulated in classical Hodgkin lymphoma. Haematologica 97: 1612-1614. doi:10.3324/haematol.2012.061770. PubMed: 22581005.
29. Ni W, Zhan Y, He H, Maynard E, Balschi JA et al. (2007) Ets-1 is a critical transcriptional regulator of reactive oxygen species and p47(phox) gene expression in response to angiotensin II. Circ Res 101: 985-994. doi:10.1161/CIRCRESAHA.107.152439. PubMed: 17872466. (Pubitemid 350084976)
30. Pearse DD, Tian RX, Nigro J, Iorgulescu JB, Puzis L et al. (2008) Angiotensin II increases the expression of the transcription factor ETS-1 in mesangial cells. Am J Physiol Renal Physiol 294: 1094-1100. doi:10.1152/ ajprenal.00458.2007. PubMed: 18337545.
31. Mader A, Bruderlein S, Wegener S, Melzner I, Popov S et al. (2007) UHO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma. Cytogenet Genome Res 119: 204-210. doi: 10.1159/000112062. PubMed: 18253030. (Pubitemid 351235052)
32. Diehl V, Kirchner HH, Schaadt M, Fonatsch C, Stein H et al. (1981) Hodgkin's disease: establishment and characterization of four in vitro cell lies. J Cancer Res Clin Oncol 101: 111-124. doi:10.1007/BF00405072. PubMed: 7276066. (Pubitemid 11051609)
33. Poppema S, De Jong B, Atmosoerodjo J, Idenburg V, Visser L et al. (1985) Morphologic, immunologic, enzymehistochemical and chromosomal analysis of a cell line derived from Hodgkin's disease. Evidence for a B-cell origin of Sternberg-Reed cells. Cancer 55: 683-690. doi:10.1002/1097-0142(19850215)55:4. PubMed: 3881158. (Pubitemid 15173503)
34. Cerchietti L, Damm-Welk C, Vater I, Klapper W, Harder L et al. (2011) Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas. PLOS ONE 6: e18436. doi:10.1371/journal.pone.0018436. PubMed: 21494621.
35. Fischer P, Nacheva E, Mason DY, Sherrington PD, Hoyle C et al. (1988) A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene. Blood 72: 234-240. PubMed: 3260522.
36. Schmitz R, Hansmann ML, Bohle V, Martin-Subero JI, Hartmann S et al. (2009) TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B-cell lymphoma. J Exp Med 206: 981-989. doi:10.1084/jem.20090528. PubMed: 19380639.
37. Martín-Subero JI, Chudoba I, Harder L, Gesk S, Grote W et al. (2002) Multicolor-FICTION: ex-panding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses. Am J Pathol 161: 413-420. doi:10.1016/S0002-9440(10)64197-1. PubMed: 12163366. (Pubitemid 36142150)
38. Giefing M, Siebert R (2013) FISH and FICTION to detect chromosomal aberrations in lymphomas. Methods Mol Biol 971: 227-244. doi:10.1007/978-1- 62703-269-8-13. PubMed: 23296967.
39. Lamprecht B, Walter K, Kreher S, Kumar R, Hummel M et al. (2010) Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat Med 16: 571-579. doi:10.1038/nm.2129. PubMed: 20436485.
40. Otto C, Giefing M, Massow A, Vater I, Gesk S et al. (2012) Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma. Br J Haematol 157: 702-708. doi:10.1111/j.1365-2141.2012.09113.x. PubMed: 22469134.
41. Zhao H, Kalivendi S, Zhang H, Joseph J, Nithipatikom K et al. (2003) Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. Free Radic Biol Med 34: 1359-1368. doi:10.1016/S0891-5849(03)00142-4. PubMed: 12757846. (Pubitemid 36570409)
42. Lü JM, Lin PH, Yao Q, Chen C (2010) Chemical and molecular mechanisms of antioxidants: Experimental approaches and model systems. J Cell Mol Med 14: 840-860. doi:10.1111/j.1582-4934.2009.00897.x. PubMed: 19754673.